XML 27 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Cash Equivalents, Restricted Cash and Investments
12 Months Ended
Dec. 31, 2019
Investments Debt And Equity Securities [Abstract]  
Cash Equivalents, Restricted Cash and Investments

3.

Cash Equivalents, Restricted Cash and Investments

Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Cash and cash equivalents

 

$

39,179

 

 

$

28,088

 

Restricted cash included in Other assets

 

 

1,080

 

 

 

 

Total cash, cash equivalents and restricted cash

 

$

40,259

 

 

$

28,088

 

 

Restricted cash as of December 31, 2019 was held as collateral for a stand-by letter of credit issued by the Company to its landlord in connection with the lease of the Company’s facility in San Carlos, California. See “Note 8. Commitments” for additional information of this lease.

3.

Cash Equivalents, Restricted Cash and Investments (continued)

Cash Equivalents and Investments

The amortized cost and fair value of cash equivalents and investments at December 31, 2019 and 2018 were as follows (in thousands):

 

 

 

December 31, 2019

 

 

 

Amortized

 

 

Gross Unrealized

 

 

Fair

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Money market fund

 

$

30,353

 

 

$

 

 

$

 

 

$

30,353

 

U.S. treasury securities

 

 

40,245

 

 

 

47

 

 

 

 

 

 

40,292

 

Commercial paper

 

 

12,429

 

 

 

 

 

 

 

 

 

12,429

 

Asset-backed securities

 

 

25,436

 

 

 

50

 

 

 

 

 

 

25,486

 

Corporate debt securities

 

 

84,605

 

 

 

225

 

 

 

(4

)

 

 

84,826

 

Total available-for-sale securities

 

$

193,068

 

 

$

322

 

 

$

(4

)

 

$

193,386

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

30,325

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

133,607

 

Long-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

29,454

 

Total available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

193,386

 

 

 

 

December 31, 2018

 

 

 

Amortized

 

 

Gross Unrealized

 

 

Fair

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Money market fund

 

$

22,073

 

 

$

 

 

$

 

 

$

22,073

 

U.S. treasury securities

 

 

23,013

 

 

 

 

 

 

(13

)

 

 

23,000

 

Commercial paper

 

 

45,683

 

 

 

 

 

 

 

 

 

45,683

 

Asset-backed securities

 

 

29,127

 

 

 

 

 

 

(34

)

 

 

29,093

 

Corporate debt securities

 

 

55,228

 

 

 

 

 

 

(151

)

 

 

55,077

 

Total available-for-sale securities

 

$

175,124

 

 

$

 

 

$

(198

)

 

$

174,926

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

26,030

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

148,896

 

Total available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

174,926

 

 

Cash equivalents in the tables above exclude cash of $8.9 million and $2.1 million as of December 31, 2019 and 2018, respectively. All available-for-sale securities held as of December 31, 2019 had contractual maturities of less than two years. There have been no significant realized gains or losses on available-for-sale securities for the periods presented. The Company applies the specific identification method to determine the cost basis of the securities sold. No available-for-sale securities held as of December 31, 2019 have been in a continuous unrealized loss position for more than 12 months. As of December 31, 2019, unrealized losses on available-for-sale investments are not attributed to credit risk and are considered to be temporary. The Company believes that it is more-likely-than-not that investments in an unrealized loss position will be held until maturity or the recovery of the cost basis of the investment. The Company believes it has no other-than-temporary impairments on its securities because it does not intend to sell these securities and it believes it is not more likely than not that it will be required to sell these securities before the recovery of their amortized cost basis. To date, the Company has not recorded any impairment charges on marketable securities related to other-than-temporary declines in market value.